Is Menthol recalled?
131 FDA recalls mention Menthol. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Menthol.
Class II · Moderate risk Terminated Jun 21, 2019
Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good…
Class II · Moderate risk Terminated Jun 21, 2019
Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good…
Class II · Moderate risk Terminated Jun 21, 2019
Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good…
Class III · Low risk Terminated Apr 25, 2019
Reason Labeling: Not Elsewhere Classified: Full cases may contain canisters that incorrectly state the net weight is 2.75 oz. rather than the correct net…
Class III · Low risk Terminated Apr 25, 2019
Reason Labeling: Not Elsewhere Classified: canisters incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.
Class II · Moderate risk Terminated Aug 3, 2018
Reason Superpotent Drug: high out of specification assay results for the menthol ingredient.
Class II · Moderate risk Terminated Aug 3, 2018
Reason Superpotent Drug: high out of specification assay results for the camphor ingredient.
Class II · Moderate risk Terminated Aug 3, 2018
Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.
Class II · Moderate risk Terminated May 25, 2018
Reason CGMP Deviations: products may be contaminated with bacteria.
Class II · Moderate risk Terminated May 16, 2018
Reason CGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products.
Class II · Moderate risk Terminated Mar 29, 2018
Reason CGMP Deviations: the product was produced with substandard GMP manufacturing processes.
Class III · Low risk Terminated Oct 30, 2017
Reason Labeling: Incorrect or Missing Lot and/or Exp Date; lot number on the secondary packaging doesnt match the lot number printed on the bottle
Class II · Moderate risk Terminated Jan 27, 2017
Reason CGMP Deviations
Class II · Moderate risk Terminated Mar 23, 2016
Reason Marketed Without An Approved NDA/ANDA: product is an unapproved drug and additionally 3 lots were found to be subpotent.
Class II · Moderate risk Terminated Jan 27, 2016
Reason Marketed without an approved NDA/ANDA
Class II · Moderate risk Terminated Sep 17, 2015
Reason Labeling: Incorrect Instructions; The word not is missing from the following sentences "do bandage tightly or cover with any type of wrap except…
Class III · Low risk Terminated Jul 2, 2015
Reason Presence of Foreign Tablets/Capsules: Presence of comingled Sugar Free Honey Lemon cough drops.
Class III · Low risk Terminated Jun 4, 2015
Reason Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol.
Class II · Moderate risk Terminated Jan 16, 2014
Reason Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due…
Class II · Moderate risk Terminated Jan 16, 2014
Reason Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due…
Class II · Moderate risk Terminated Jan 16, 2014
Reason Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due…
Class II · Moderate risk Terminated Jan 16, 2014
Reason Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due…
Class II · Moderate risk Terminated Jan 16, 2014
Reason Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due…
Class II · Moderate risk Terminated Jul 2, 2013
Reason Labeling:Label Mixup; BENZOCAINE/MENTHOL Lozenge, 15 mg/2.6 mg may be potentially mislabeled as CHOLECALCIFEROL/ CALCIUM/ PHOSPHORUS, Tablet, 120…
Class II · Moderate risk Terminated Jul 2, 2013
Reason Labeling:Label Mixup; BENZOCAINE/MENTHOL Lozenge, 15 mg/3.6 mg may be potentially mislabeled as LUBIPROSTONE, Capsule, 24 mcg, NDC 64764024060…